Product Description
Dasatinib Tablets
Tags: Dasatinib Tablets manufacturer, Dasatinib Tablets exporter, Dasatinib Tablets supplier, DasatinibTablets, ,Dasatinib potassium, whogmp approved ,Dasatinib potassium tabletsmanufacturer and supplier ,Dasatinib Tablets distributor, Dasatinib Tabletsdrop shipper, Dasatinib Tablets 70 mg, Dasatinib Tablets 70 mg supplier, DasatinibTablets 70 mg.
ISO/GMP/c-GMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: SaintroyLifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples, COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free sale certificate and other required documents.
Export Country : SaintroyLifescience export Dasatinib Tablets to USA, Canada, Germany, Europe,France, Ghana, Nigeria, Kenya, Senegal, Sudan, UAE, Kuwait, Dubai, Cameroon,Lebanon, Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand,Singapore, Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, Ivory Costa, Oman, Guatemala,Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia,Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan,Uzbekistan, Kazakhstan.
Powerful Therapy for LeukemiaDasatinib Tablets provide an effective oral treatment for patients with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). By targeting specific proteins involved in cancer cell growth, Dasatinib disrupts abnormal cell proliferation, offering important therapeutic benefits for patients who require long-term cancer management.
Convenient Dosage VarietiesThe tablets are available in five different strengths-20 mg, 50 mg, 70 mg, 80 mg, and 100 mg-to allow individualized dosing as per the treatment plan set by your healthcare provider. Packaged in either blister packs or bottles, the product meets varying market preferences, ensuring convenient and safe storage.
Patient Counseling and Safety MeasuresPatients are advised to swallow Dasatinib Tablets whole with water; do not crush, split, or chew the tablet. Regular monitoring of liver function and blood counts is essential during therapy. Use is contraindicated in cases of hypersensitivity to Dasatinib or other tablet components, and it should be avoided in pregnancy unless clearly required.
FAQ's of Dasatinib Tablets:
Q: How should Dasatinib Tablets be taken for best results?
A: Take Dasatinib Tablets orally as prescribed by your healthcare professional, with or without food. Swallow the tablet whole with water, and never split, crush, or chew it. Always follow your doctor's instructions regarding dosage and timing for optimal effectiveness.
Q: What cancers are Dasatinib Tablets used to treat?
A: Dasatinib Tablets are specifically indicated for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), helping to prevent cancer cell growth and reduce disease progression.
Q: When should I contact my doctor during Dasatinib therapy?
A: You should contact your doctor immediately if you notice signs of myelosuppression (such as frequent infections or unusual bleeding), severe fluid retention, or any other unexpected symptoms. Routine monitoring of liver function and platelet counts is required throughout treatment.
Q: Where should I store Dasatinib Tablets to maintain their efficacy?
A: Store Dasatinib Tablets in a place below 30C, protected from moisture and direct light. Use the original blister pack or bottle, and keep out of reach of children and pets for safety.
Q: What precautions should be observed while on Dasatinib treatment?
A: Precautions include monitoring liver function and blood cell counts, avoiding use during pregnancy unless absolutely necessary, and informing your doctor about any allergies. Use is not advised if you have known hypersensitivity to Dasatinib or its excipients.
Q: What are the common side effects of Dasatinib Tablets?
A: Frequently reported side effects include myelosuppression, fluid retention, nausea, diarrhea, and skin rash. If any of these become severe or persistent, report them promptly to your healthcare provider.